Benjamin F. Edwards & Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $17.6M | Buy |
223,946
+1,185
| +0.5% | +$97.1K | 0.31% | 94 |
|
|
2024
Q1 | $19.4M | Sell |
222,761
-1,759
| -0.8% | -$150K | 0.35% | 79 |
|
|
2023
Q4 | $18.5M | Buy |
224,520
+182,561
| +435% | +$13.9M | 0.37% | 79 |
|
|
2023
Q3 | $3.29M | Buy |
41,959
+523
| +1% | +$43.8K | 0.13% | 159 |
|
|
2023
Q2 | $3.65M | Buy |
41,436
+1,507
| +4% | +$130K | 0.14% | 151 |
|
|
2023
Q1 | $3.22M | Buy |
39,929
+6,081
| +18% | +$496K | 0.13% | 155 |
|
|
2022
Q4 | $2.63M | Sell |
33,848
-4,478
| -12% | -$363K | 0.12% | 175 |
|
|
2022
Q3 | $3.1M | Sell |
38,326
-94
| -0.2% | -$8.45K | 0.16% | 142 |
|
|
2022
Q2 | $3.45M | Buy |
38,420
+1,600
| +4% | +$162K | 0.17% | 142 |
|
|
2022
Q1 | $4.08M | Sell |
36,820
-1,985
| -5% | -$210K | 0.18% | 125 |
|
|
2021
Q4 | $4.01M | Buy |
38,805
+3,412
| +10% | +$395K | 0.18% | 124 |
|
|
2021
Q3 | $4.44M | Buy |
35,393
+1,256
| +4% | +$163K | 0.22% | 103 |
|
|
2021
Q2 | $4.24M | Sell |
34,137
-1,781
| -5% | -$224K | 0.22% | 106 |
|
|
2021
Q1 | $4.24M | Buy |
35,918
+1,053
| +3% | +$123K | 0.23% | 107 |
|
|
2020
Q4 | $4.08M | Buy |
34,865
+120
| +0.3% | +$13.2K | 0.24% | 104 |
|
|
2020
Q3 | $3.61M | Buy |
34,745
+27
| +0.1% | +$2.71K | 0.24% | 100 |
|
|
2020
Q2 | $3.18M | Sell |
34,718
-7,797
| -18% | -$748K | 0.23% | 112 |
|
|
2020
Q1 | $3.83M | Buy |
42,515
+640
| +2% | +$68.1K | 0.33% | 78 |
|
|
2019
Q4 | $4.75M | Sell |
41,875
-275
| -0.7% | -$30.2K | 0.33% | 75 |
|
|
2019
Q3 | $4.58M | Sell |
42,150
-304
| -0.7% | -$31.7K | 0.36% | 67 |
|
|
2019
Q2 | $4.13M | Buy |
42,454
+10,961
| +35% | +$1M | 0.35% | 67 |
|
|
2019
Q1 | $2.87M | Buy |
31,493
+4,551
| +17% | +$407K | 0.26% | 95 |
|
|
2018
Q4 | $2.45M | Buy |
26,942
+1,087
| +4% | +$102K | 0.25% | 91 |
|
|
2018
Q3 | $2.54M | Buy |
25,855
+2,849
| +12% | +$263K | 0.24% | 102 |
|
|
2018
Q2 | $1.97M | Sell |
23,006
-26
| -0.1% | -$2.17K | 0.19% | 119 |
|
|
2018
Q1 | $1.85M | Buy |
23,032
+1,011
| +5% | +$83.4K | 0.19% | 123 |
|
|
2017
Q4 | $1.78M | Buy |
22,021
+1,421
| +7% | +$114K | 0.19% | 131 |
|
|
2017
Q3 | $1.6M | Buy |
20,600
+7,988
| +63% | +$663K | 0.19% | 117 |
|
|
2017
Q2 | $1.12M | Buy |
12,612
+1,269
| +11% | +$107K | 0.15% | 145 |
|
|
2017
Q1 | $914K | Sell |
11,343
-2,890
| -20% | -$226K | 0.13% | 168 |
|
|
2016
Q4 | $1.01M | Buy |
14,233
+3,961
| +39% | +$311K | 0.17% | 144 |
|
|
2016
Q3 | $888K | Buy |
10,272
+597
| +6% | +$52K | 0.16% | 144 |
|
|
2016
Q2 | $839K | Sell |
9,675
-386
| -4% | -$31.2K | 0.16% | 141 |
|
|
2016
Q1 | $755K | Sell |
10,061
-89
| -0.9% | -$6.7K | 0.16% | 142 |
|
|
2015
Q4 | $781K | Sell |
10,150
-3,312
| -25% | -$249K | 0.17% | 135 |
|
|
2015
Q3 | $901K | Sell |
13,462
-311
| -2% | -$22.9K | 0.2% | 112 |
|
|
2015
Q2 | $1.02M | Buy |
13,773
+2,346
| +21% | +$179K | 0.2% | 108 |
|
|
2015
Q1 | $891K | Sell |
11,427
-782
| -6% | -$59.3K | 0.19% | 121 |
|
|
2014
Q4 | $881K | Buy |
12,209
+681
| +6% | +$47.3K | 0.2% | 110 |
|
|
2014
Q3 | $714K | Buy |
11,528
+1,245
| +12% | +$79.2K | 0.18% | 133 |
|
|
2014
Q2 | $656K | Buy |
10,283
+141
| +1% | +$8.56K | 0.17% | 139 |
|
|
2014
Q1 | $624K | Buy |
10,142
+1,767
| +21% | +$103K | 0.17% | 142 |
|
|
2013
Q4 | $481K | Buy |
8,375
+657
| +9% | +$37.3K | 0.16% | 152 |
|
|
2013
Q3 | $411K | Sell |
7,718
-129
| -2% | -$6.94K | 0.15% | 155 |
|
|
2013
Q2 | $404K | Buy |
+7,847
| New | +$388K | 0.16% | 144 |
|
Other funds holding MDT
Benjamin F. Edwards & Company's MDT Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Medtronic (MDT) stake by 0.53% in Q2 2024, buying an estimated $97.1K and bringing the position to 223,946 shares worth $17.6M. The position accounts for 0.31% of the portfolio, ranked #94.
Benjamin F. Edwards & Company first reported a position in MDT in Q2 2013 and has held it in 45 quarters since. The position peaked at $19.4M in Q1 2024. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Benjamin F. Edwards & Company held 223,946 shares of Medtronic worth $17.6M as of Q2 2024.
- Benjamin F. Edwards & Company bought 1,185 Medtronic shares in Q2 2024, an estimated $97.1K.
- Medtronic made up 0.31% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #94 holding.
- Benjamin F. Edwards & Company first reported a position in Medtronic in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Medtronic position peaked at $19.4M in Q1 2024.
- 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.